Switching Stable Kidney Transplant Recipients to a Generic Tacrolimus Is Feasible and Safe, but It Must Be Monitored

Background. Tacrolimus is the primary immunosuppressive drug used in kidney transplant patients. Replacing brand name products with generics is a controversial issue that we studied after a Chilean Ministry of Health mandate to implement such a switch. Methods. Forty-one stable Prograf (Astellas) re...

Descripción completa

Detalles Bibliográficos
Autores principales: González, Fernando, López, René, Arriagada, Elizabeth, Carrasco, René, Gallardo, Natalia, Lorca, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299171/
https://www.ncbi.nlm.nih.gov/pubmed/28246556
http://dx.doi.org/10.1155/2017/5646858

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299171/
https://www.ncbi.nlm.nih.gov/pubmed/28246556
http://dx.doi.org/10.1155/2017/5646858

Ejemplares similares